The transjugular intrahepatic portosystemic shunt

Journal of Hepatology

Volumn 25, Issue 2, 1996, Pages 224-231

  Rössle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASCITES; HUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; VARIX BLEEDING;

EID: 0030221446     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80079-1     Document Type: Review

References (62)

1. D'Amico G., Pagliaro L., Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 22:1995;332-354.
2. Rössle M., Richter G.M., Nöldge G., Haag K., Wenz W., Gerok W., Palmaz J.C. Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique: a case report. Hepatology. 8:1988;1348A.
3. Perarnau J.M., Raabe J.J., Schwing D., Rucin B., Arbogast J., Rössle M. Anastomose porto-cave transjugulaire. Ann Chir. 47:1993;407-413.
4. LaBerge J.M., Ring E.J., Gordon R.L., Lake J.R., Doherty M.M., Somberg K.A., Roberts J.P., Ascher N.L. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: results in 100 patients. Radiology. 187:1993;413-420.
5. Rössle M., Haag K., Ochs A., Sellinger M., Nöldge G., Perarnau J.M., Berger E., Blum U., Gabelmann A., Hauenstein K.H., Langer M., Gerok W. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 330:1994;165-171.
6. LaBerge J.M., Somberg K.A., Lake J.R., Gordon R.L., Kerlan R.M., Asher N.L., Roberts J.P., Simor M.M., Doherty C.A., Hahn J., Bacchetti P., Ring E.J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 108:1995;1143-1151.
7. Theilmann L., Sauer P. Transjugular intrahepatic portosystemic stent-shunt: results and complications. Radiologe. 34:1994;174-177.
8. Richter G.M., Nöldge G., Roeren T., Kauffmann G.W., Palmaz J.C. Historic and conceptual aspects of TIPSS. Radiologe. 34:1994;158-164.
9. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg. 165:1993;566-571.
10. Martin M, Zajko AB, Orons PD, Dodd G, Wright H, Colangelo J, Tartar R. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery. 114:1993;719-727.
11. Simpson KJ, Chalmers N., Redhead D.N, Finlayson NDC, Bouchier IAD, Hayes PC. Transjugular intrahepatic portasystemic stent shunting for control of acute and recurrent upper gastrointestinal hemorrhage related to portal hypertension. Gut. 34:1993;968-973.
12. Hausegger KA, Sternthal HM, Klein GE, Karaic R, Stauber R, Zenker G. Transjugular intrahepatic portosystemic shunt: angiographic follow-up and secondary interventions. Radiology. 191:1994;177-181.
13. Lind CD, Malisch TW, Chong WK, Richards WO, Pinson CW, Meranze SG, Mazer M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology. 106:1994;1277-1283.
14. Van Buuren HR, Cheng KH, Pieterman H, Schalm SW, Lameris JS. Transjugular intrahepatic portosystemic shunt. Requiem for the surgical shunt? Scand J Gastroenterol. 28:1993;48-52. Suppl 200.
15. Zemel G, Katzen BT, Becker GJ, Benenati JF, Sallee S. Percutaneous transjugular portosystemic shunt. JAMA. 266:1991;390-393.
16. Freedman AM, Sanyal AJ, Tisnado J, Shiffman ML, Luketic VA, Fisher RA, Posner MP. Results with percutaneous transjugular intrahepatic portosystemic stent-shunt for control of vericeal hemorrhage in patients awaiting liver transplantation. Transplant Proc. 25:1993;1087-1089.
17. Rubin RA, Haskal ZJ, O'Brien CB, Cope C, Brass CA. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol. 90:1995;556-563.
18. Sanyal AJ, Freedman AM, Shiffman MI, Purdum PP, Luketin VA, Tisnado J, Cole P. Transjugular intrahepatic portosystemic shunt (TIPS) for uncontrolled variceal hemorrhage in advanced cirrhotics at high risk for surgery: a prospective study. Gastroenterology. 104:1993;A985.
19. Haag K, Rössle M, Hauenstein KH, Sellinger M, Ochs A, Blum U, Langer M, Gerok W. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the emergency treatment of portal hypertension. Intensivmed. 30:1993;479-483.
20. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA, Tisnado J, Cole P. Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy for prevention of recurrent variceal hemorrhage: a randomized prospective trial. Gastroenterology. 106:1994;A975.
21. Cabrera J, Maynar M, Granados R, Gorriz E, Presa F, Reyes R, Pulido-Duque JM, Guerra C, Kravetz D. Transjugular intrahepatic portosystemic shunt (TIPS) vs sclerotherapy in the elective treatment of variceal bleeding. Hepatology. 20:1994;A425.
22. Rössle M, Deibert P, Haag K, Ochs A, Siegerstetter V, Langer M. TIPS versus sclerotherapy and β-blockade: preliminary results of a randomized study in patients with recurrent variceal hemorrhage. Hepatology. 20:1994;A44.
23. Merli M, Riggio Oia I, Capocaccia L, Ziparo VA, Bolognese A, Rossi PF, Salerno F. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic sclerotherapy (EST) in preventing variceal rebleeding: preliminary results of a randomized controlled trial. Hepatology. 20:1994;A43.
24. Chavez DR, Snyder PM, Juravsky LI, Heaney JA. Recurrent ileal conduit hemorrhage in an elderly cirrhotic man. J Urol. 152:1994;951-953.
25. Haskal ZJ, Scott M, Rubin RA, Cope C. Intestinal varices: treatment with the transjugular intrahepatic portosystemic shunt. Radiology. 191:1993;183-187.
26. Saito H, Sakurai J, Takamura A, Hasegawa T, Usubuchi H, Hanawa M, Mortia Y. A case of ruptured multiple mesenteric varices successfully treated by transjugular intrahepatic portosystemic stent shunt (TIPS). Nippon ShokakibyoGakkat Zassbi. 91:1994;1032-1036.
27. Katz J, Rubin R, Cope C, Holland G, Brass CA. Recurrent bleeding from anorectal varices: successful treatment with a transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 88:1993;1104-1107.
28. Lagier E, Roussau H, Maquin P, Olives JP, Le Tallec C, Vinel JP. Treatment of bleeding stomal varices using transjugular intrahepatic portosystemic shunt. J Pediatr Gastroenterol Nutr. 18:1994;501-503.
29. Orloff MJ. Pathogenesis and surgical treatment of intractable ascites associated with alcoholic cirrhosis. Ann N Y Acad Sci. 170:1970;213-238.
30. Burchell AR, Rousselot LM, Panke WF. A seven-year experience with side-to-side portacaval shunt for cirrhotic ascites. Ann Surg. 168:1968;655-670.
31. Villarreal LG, Urmeneta JMZ, Vila JQ, Gomez-Acebo BS, Jaureguizar JIB, Areso JL, Valtuena JP. Portosystemic intrahepatic prosthesis: PIP (TIPS) in the treatment of refractory ascites. A pilot study. Gastroenterol Hepatol. 16:1993;18-22.
32. Ferral H, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, Tadavarthy SM, Hunter DW, Castaneda-Zuniga WR. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology. 189:1993;795-801.
33. Benner KG, Sahagun G, Saxon R, Barton RE, Keller F, Rabkin J, Reed M, Rösch J. Selection of patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites. Hepatology. 20:1994;114A. (Pt. 2).
34. Somberg K, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology. 21:1995;709-716.
35. Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med. 332:1995;1192-1197.
36. Quiroga J, Sangro B, Nunez M, Bilbao I, Longo J, Garcia-Villarreal L, Zozaya JM, Betes M, Herrero JI, Prieto J. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 21:1995;986-994.
37. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Lassen C, Poynard T. Transjugular intrahepatic portosystemic shunt (TIPS) vs paracentesis for refractory ascites: results of a randomized trial. Hepatology. 20:1994;201A. (Pt 2).
38. Ochs A, Rössle M, Haag K, Gerbes A, Morgenroth P, Deibert P, Hauenstein KH, Langer M, Gerok W. TIPS for hepatorenal syndrome. Hepatology. 20:1994;114A. (Pt. 2).
39. Lake JR, Ring EJ, LaBerge JM, Gordon RL, Roberts JP, Asher NL. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc. 25:1993;1766-1767.
40. Sanyal AJ, Gehr T, Freedman AM, Purdum PP, Shiffman ML, Lucetic VA, Moore EW, Cole P, Tisnado J. Increased splanchnic Endothelin-1 plays a role in the pathogenesis of ascites. Hepatology. 20:1994;113A. (Pt.2).
41. Martinet JP, Legault L, Cernacek P, Colombato L, Roy L, Fenyves D, Dufresne MP, Pomier-Layrargues G. Effect of TIPS on splanchnic and renal production of endothelins. Hepatology. 20:1994;113A. (Pt.2).
42. Gerbes AL, Moller S, Gulberg V, Henriksen JH. Endothelin-1 and -3 plasma concentration in patients with cirrhosis: role of splanchnic and renal passage and liver functions. Hepatology. 21:1995;735-739.
43. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 327:1992;1774-1778.
44. Strauss R.M, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portosystemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol. 89:1994;1520-1522.
45. Ochs A, Sellinger M, Haag K, Nöldge G, Herbst EW, Walter E, Gerok W, Rössle M. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol. 18:1993;217-225.
46. Blum U, Rössle M, Haag K, Ochs A, Hauenstein KH, Langer M. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of Budd-Chiari syndrome. Radiology. 197:1993;805-811.
47. Peltzer MY, Ring EJ, LaBerge JM, Haskal ZJ, Radosevich PM, Gordon RL. Treatment of Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol. 4:1993;263-267.
48. Blum U, Haag K, Rössle M, Ochs A, Gabelmann A, Boos S, Langer M. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 195:1995;153-157.
49. Radosevich PM, Ring EJ, LaBerge JM, Peltzer MY, Haskal ZJ, Doherty MM, Gordon RL. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology. 186:1993;523-527.
50. Ring EJ, Lake JR, Roberts JP, LaBerge JM, Read AE, Sterneck MR, Ascher NL. Using transjugular intrahepatic porto-systemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med. 116:1992;304-309.
51. Freeman RB, FitzMaurice SE, Greenfield AE, Halin N, Haug CE, Rohrer RJ. Is the transjugular intrahepatic portocaval shunt procedure beneficial for liver transplant recipients? Transplantation. 58:1994;297-300.
52. Somberg KA. The NIADDK Liver Transplantation Database. Transjugular intrahepatic portosystemic shunts (TIPS) have a limited impact on the liver transplant operation. (Abstract) Gastroenterology. 106:1994;A989.
53. Menegaux F, Keeffe EB, Baker E, Egawa H, Conception W, Russell TR, Esquivel CO. Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. Arch Surg. 129:1994;1018-1024.
54. Sellinger M, Ochs A, Haag K, Nöldge G, Gerok W, Rössle M. Incidence of hepatic encephalopathy and follow-up of liver function in patients with transjugular intrahepatic porto-systemic stent-shunt (TIPS). Gastroenterology. 102:1992;883A.
55. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 20:1994;46-55.
56. Somberg KA, Riegler JL, LaBerge JM, Doherty-Simor MM, Bachetti P, Roberts JP, Lake JR. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol. 90:1995;549-555.
57. Hauenstein KH, Haag K, Ochs A, Langer M, Rössle M. Reducing stent for TIPS-induced refractory hepatic encephalopathy and liver failure. Radiology. 194:1994;175-179.
58. Haag K, Nöldge G, Sellinger M, Ochs A, Gerok W, Rössle M. Transjugular intrahepatic portosystemic stent-shunt (TIPS): monitoring of function by color duplex sonography. Gastroenterology. 102:1992;A817.
59. Krause T, Siegerstetter V, Haag K, Hauenstein KH, Rössle M. Evaluation of thrombogenicity of metallic stents in patients with TIPS using technetium-99m labelled platelets. Eur J Nucl Med. 21:1994;741A.
60. Sauer P, Theilmann L, Richter G, Roeren T, Stremmel W, Stiehl A. Phenprocoumon for prevention of early shunt occlusion after transjugular intrahepatic portosystemic stentshunt (TIPS): results of a randomized trial. Gastroenterology. 108:1995;A1164.
61. Theilmann L, Sauer P, Roeren T, Otto G, Arnold JC, Nöldge G, Richter G, Stiehl A. Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portosystemic stent shunts: a controlled study. Hepatology. 20:1994;592-597.
62. Epstein M. Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol. 4:1994;1735-1753.